VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s share price traded up 17.2% on Wednesday . The company traded as high as C$0.17 and last traded at C$0.17. 126,000 shares changed hands during trading, a decline of 57% from the average session volume of 290,886 shares. The stock had previously closed at C$0.15.
VentriPoint Diagnostics Stock Performance
The business has a fifty day moving average of C$0.10 and a 200-day moving average of C$0.13. The company has a market cap of C$26.76 million, a PE ratio of -5.10 and a beta of 0.39. The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of -58.56.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- What Are Dividend Champions? How to Invest in the Champions
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Why Energy Transfer Belongs on Your Watchlist
- EV Stocks and How to Profit from Them
- Why Wayfair Stock May Be a Hidden Gem for Value Investors
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
